Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs

Journal of the National Cancer Institute

Volumn 85, Issue 8, 1993, Pages 632-639

  Chaudhary, Preet M ^a   Roninson, Igor B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CISPLATIN; COMPLEMENTARY DNA; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; HYDROXYUREA; MESSENGER RNA; METHOTREXATE; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PROTEIN KINASE C; STAUROSPORINE; VINBLASTINE;

ARTICLE; CANCER CHEMOTHERAPY; CARCINOMA CELL; CELL SUBPOPULATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; DRUG RESISTANCE; ENZYME INHIBITORS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MEMBRANE GLYCOPROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; POLYMERASE CHAIN REACTION; PROTEIN KINASE C; RNA, MESSENGER; RNA, NEOPLASM; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0027506202     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/85.8.632     Document Type: Article

References (42)

1. Roninson IB. ed: Molecular and Cellular Biology of Multidmg Resistance in Tumor Cells. New York: Plenum Press, 1991
2. Schinkel AH, Borst P: Multidrug resistance mediated by P-glycopro-teins. Semin Cancer Biol 2:213-226, 1991
3. Dalton WS, Miller TP: Multidrug resistance. In Principles and Practice of Oncology (DeVita VT Jr. Heilman S, Rosenberg SA, eds), 3rd ed. Updates 5(7). Philadelphia: Lippincott, 1991. pp 1-13
4. Goldstein LJ, Galski H, Fojo A, et al: Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81:116-124, 1989
5. Noonan KE, Beck C, Holzmayer TA, et al: Quantitative analysis of MDRI (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc Natl Acad Sci U S A 87:7160-7164, 1990
6. Chan HS. Thorner PS. Haddad G, et al: Immunohistochemical detection of P-glycoprotein: Prognostic correlation in soft tissue sarcoma of childhood. J Clin Oncol 8:689-704, 1990
7. Chan HS, Haddad G, Thorner PS, et al: P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N Engl J Med 325:1608-1614, 1991
8. Cameos L, Guyotat D, Archimbaud E, et al: Clinical significance of multidrug resistance P-glycoprotein expression on acute non-lymphoblaslic leukemia cells at diagnosis. Blood 79:473-476, 1992
9. Holzmayer TA, Hilsenbeck S, Von Hoff DD, et al: Clinical correlates of MDRI (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst 84:1486-1491, 1992
10. Goldie JH, Coldman AJ: Genetic instability in the development of drug resistance. Semin Oncol 12:222-230, 1985
11. Chin KV, Chauhan SS, Pastan I, et al: Regulation of mdr RNA levels in response to cytotoxic drugs in rodent cells. Cell Growth Diff 1:361-365, 1991
12. Licht T, Fiebig HH, Bross KJ, et al: Induction of multiple-drug resistance during anti-neoplastic chemotherapy in vitro. Int J Cancer 49:630-637, 1991
13. Thorgeirsson SS, Huber BE, Sorell S, et al: Expression of the multidnig resistance gene in hepatocarcinogenesis and regenerating rat liver. Science 236:1120-1122, 1987
14. Fairchild CR, Ivy SP, Rushmore T, et al: Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. Proc Natl Acad Sci USA 84:7701-7705, 1987
15. Chin KV, Tanaka S, Darlington G, et al: Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. J Biol Chem 265:221-226, 1990
16. Kioka N, Hosokawa N, Komano T, et al: Quercetin, a bioflavonoid, inhibits the increase of human multidrug resistance gene (MDR1) expression caused by arsenite. FEBS Len 3:307-309, 1992
17. Mickley LA, Bates SE, Richert ND, et al: Modulation of the expression of a multidrug resistance gene (mdr-l/P-glycoprotein) by differentiating agents. J Biol Chem 264:18031-18040, 1989
18. Bates SE, Mickley LA, Chen YN, et al: Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentiation. Mol Cell Biol 9:4337-4344, 1989
19. Kohno K, Sato S, Takano H, et al: The direct activation of human multidrug resistance gene (MDR1) by anticancer agents. Biochem Biophys Res Commun 165 1415-1421, 1989
20. Tanimura H, Kohno K, Sato S, et al: The human multidrug resistance 1 promoter has an element that responds to serum starvation. Biochem Biophys Res Commun 183:917-924, 1992
21. Kharbanda S, Datta R, Kufe D: Regulation of c-jun gene expression in HL-60 leukemia cells by 1 -p-D-arabinofuranosylcytosirtc. Potential involvement of a protein kinase C dependent mechanism. Biochemistry 30:7947-7952, 1991
22. Posada J, Vichi P, Tritton TR: Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49:6634-6639, 1989
23. Rubin E, Kharbanda S, Gunii H, et al: cis-Diamminedi-chloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: Potential involvement of a protein kinase C-dependent signaling pathway. Cancer Res 52:878-882, 1992
24. Chaudhary PM, Roninson LB: Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists. Oncology Res 4:281-290, 1992
25. Pauwels R, Balzarini J, Baba M, et al: Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds. J Virol Methods 20:309-321, 1988
26. Chaudhary PM, Roninson IB: Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 66:85-94, 1991
27. Mechetner EB, Roninson IB: Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci U S A 89:5824-5828, 1992
28. Peppel K, Baolioni C: A simple and fast method to extract RNA from tissue culture cells. Biotechmques 9:711-713, 1990
29. Neyfakh AA: Use of fluorescent dyes as molecular probes for the study of multidrug resistance. Exp Cell Res 174:168-176, 1988
30. Pelosin JM, Keramidas M, Souvionet C, et al: Differential inhibition of protein kinase C subtypes. Biochem Biophys Res Commun 169:1040-1048, 1990
31. Hidaka H, Inaoaki M, Kawamoto S, et al: Isoquinoline-sulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C. Biochemistry 23:5036-5041, 1984
32. Young RC: Drug resistance: The clinical problem. In Drug Resistance in Cancer Therapy (Ozols RF, ed) Boston: Kluwer Acad Publ, 1989, pp 1-12
33. Papathanasiou MA, Fornace AJ: DNA-damage inducible genes. In Molecular and Clinical Advances in Anticancer Drug Resistance (Ozols RF, ed). Boston: Kluwer Acad Publ, 1991, pp 134-136
34. Fine RL, Patel J, Chabner BA: Phorbol esters induce multidrug resistance in human breast cancer cells. Proc Natl Acad Sci U S A 85:582-586, 1988
35. O’Brian CA, Fan D, Ward NE, et al: Level of protein kinase C activity correlates directly with resistance to adriamycin in murine fibrosarcoma cells. FEBS Lett 246:78-82, 1989
36. Posada JA, McKeegan EM, Worthington KF, et al: Human multidrug resistant KB cells overexpress protein kinase C: Involvement in drug resistance. Cancer Commun 1:285-292, 1989
37. Gschwendt M, Horn F, Ktttstein W, et al: Calcium and phospholipid-dependent protein kinase activity in mouse epidermis cytosol. Stimulation by complete and incomplete tumor promoters and inhibition by various compounds. Biochem Biophys Res Commun 124:63-68, 1984
38. Kantengwa S, Polla BS: Flavonoids, but not protein kinase C inhibitors, prevent stress protein synthesis during erythrophagocytosis. Biochem Biophys Res Commun 180:308-314, 1991
39. Angel P, Imagawa M, Chiu R, et al: Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated transacting factor. Cell 49:729-739, 1987
40. Lee W, Mitchell P, Tjian R: Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49:741-752, 1987
41. Ueda K, Pastan I, Gottesman MM: Isolation and sequence of the promoter region of the human multidrug resistance (P-glycoprotein) gene. J Biol Chem 262:17432-17436, 1987
42. Hsu SI, Cohen D, Kirschner LS, et al: Structural analysis of the mouse mdrla (P-glycoprotein) promoter reveals the basis for differential transcript heterogeneity in multidrug-resistant J774.2 cells. Mol Cell Biol 10:3596-3606, 1990